News + PR
OU–Industry Collaboration Harnesses AI to Accelerate Antibody Drug Production
February 10, 2026
Learn more from Wheeler Bio’s Co-Founder & CEO, Jesse McCool, about how Wheeler’s innovative Portable CMC™ platform, comprehensive suite of development tools, and state-of-the-art facilities allow innovators to maintain momentum in therapeutic development in our webinar, “Solving for Speed in Translational CMC”.